From Pharma Marketing Network Publishing
THE NEW BOOK FROM R.J. LEWIS
Intelligence is free.
Permission isn’t.

Beyond ResultsPharmaceutical & Healthcare Marketing in the AI AgeBY R.J. LEWIS
Trending Now
LATEST ARTICLES
Publicis Bought LiveRamp. Now Neutrality Is Part of the Product.
Publicis Groupe completed its acquisition of LiveRamp on November 2, 2026. Can shared marketing infrastructure remain neutral when one of the world's largest advertising...
A Patent Settlement Just Rewrote Liquidia’s Target List.
One patent settlement can make a pharmaceutical sales team's target list obsolete almost overnight. That is the overlooked story behind Liquidia's October 2026 agreement...
PrEP Marketing Has a New Job: Help Patients Choose, Not Just Know.
Knowing that HIV prevention exists is not the same as knowing which option fits someone's life. That's why helping patients understand their PrEP options...
Protected: R.J. Lewis’s New Book, Beyond Results: Pharmaceutical & Healthcare Marketing in the AI...
A decade after RESULTS, R.J. Lewis examines what AI really changes for pharma and healthcare marketing, and what it doesn't
November 13, 2026: Beyond Results:...
CMS Just Made the “New Formulation” Playbook Less Valuable.
A new delivery method can give an established drug a fresh commercial story. Now, CMS is changing the rules. CMS's latest Medicare decision could...
Summer Was Over. BMS Launched the Melanoma Campaign Anyway.
Autumn leaves usually signal the end of summer. For Bristol Myers Squibb Canada, they became a reason to revisit skin health. Its November 2026...
Pharma TV Spending Dropped 14.5%. Baseball May Be Part of the Reason.
A 14.5% drop in prescription drug TV spending sounds like an industry retreat. But what if part of the decline came from a shorter...
Ro Treats Patients. Now It Wants Their Care Journeys to Become Research.
A patient starts a GLP-1 medication online, reports side effects, and returns for follow-up care. Each interaction creates information about what treatment looks like...
The App Said “BEST Drugs.” The Court Said That Was Advertising.
Can a health app advertise a drug without showing an ad? South Korea's DoctorNow case shows why prescription app design deserves closer scrutiny. Its...
“DNA Medicine” Is a Breakthrough. It’s Also a Messaging Problem.
As Voceryq moves toward launch, DNA medicine commercialization faces a challenge that has little to do with the science: explaining what this unfamiliar treatment...






















